Fibromyalgia is still seen as less than legitimate in the medical world. Fortunately, some researchers believe otherwise and many are working on various approaches in treating the condition. The recent drug which received a fast track status from the FDA is IMC-1. This drug is a type of viral suppression drug that showed promising results in treating fibromyalgia.
The Theory between IMC-1 for Fibromyalgia
As mentioned, IMC-1 is a type of viral suppression drug invented and studied by Innovative Med Concepts (IMC) for the treatment fibromyalgia. The main purpose of the drug is to suppress viruses in the body. The theory behind IMC-1 is that the chronic pain syndrome may be related to herpes virus, which lies dormant in the body tissues. Researchers observed that fibromyalgia exhibit the same symptoms with other diseases linked to herpes. They believed that the dormant herpes virus may play a part in triggering and maintaining the symptoms of fibromyalgia. One of the most common fibro symptoms is widespread chronic pain. Others are sleep problems, overwhelming fatigue and mood problems. Many of fibro patients may also suffer from frequent headaches, IBS and cognitive impairment, famously known as the fibro fog.